Single-cell imaging of human cancer xenografts using adult immunodeficient zebrafish.
Single-cell imaging of human cancer xenografts using adult immunodeficient zebrafish.
复制标题
DOI:
10.1038/s41596-020-0372-y
复制
发表时间:
2020-09
期刊:
影响因子:
14.8
通讯作者:
Langenau DM
中科院分区:
文献类型:
--
作者:
Yan C;Do D;Yang Q;Brunson DC;Rawls JF;Langenau DM
Zebrafish are an ideal cell transplantation model. They are highly fecund, optically clear and an excellent platform for preclinical drug discovery studies. Traditionally, xenotransplantation has been carried out using larval zebrafish that have not yet developed adaptive immunity. Larval engraftment is a powerful short-term transplant platform amenable to high-throughput drug screening studies, yet animals eventually reject tumors and cannot be raised at 37 °C. To address these limitations, we have recently developed adult casper-strain prkdc−/−, il2rgα−/− immune compromised zebrafish that robustly engraft human cancer cells for in excess of 28 days. Because the adult zebrafish can be administered drugs by oral gavage or intraperitoneal injection, our model is suitable for achieving accurate, preclinical drug dosing. Our platform also allows facile visualization of drug effects in vivo at single cell resolution over days. Here, we describe the procedures for xenograft cell transplantation into the prkdc−/−, il2rgα−/− model, including refined husbandry protocols for optimal growth and rearing of immune suppressed zebrafish at 37 °C; optimized intraperitoneal and periocular muscle cell transplantation; and epifluorescence and confocal imaging approaches to visualize the effects of administering clinically relevant drug dosing at single cell resolution in vivo. Following identification of adult homozygous animals, this procedure takes 35 days to complete. 7 days are required to acclimate adult fish to 37°C and 28 days are required for engraftment studies. Our protocol provides a comprehensive guide for using immune compromised zebrafish for xenograft cell transplantation and credentials the model as a new preclinical drug discovery platform. This protocol describes how to engraft human cancer cells in immune compromised adult zebrafish. The fish are first adapted to 37°C, followed by intraperitoneal or periocular muscle transplantation of xenograft cells and fluorescence imaging.
登录
查看更多内容
影响因子:
64.8
作者:
Bakhoum SF;Ngo B;Laughney AM;Cavallo JA;Murphy CJ;Ly P;Shah P;Sriram RK;Watkins TBK;Taunk NK;Duran M;Pauli C;Shaw C;Chadalavada K;Rajasekhar VK;Genovese G;Venkatesan S;Birkbak NJ;McGranahan N;Lundquist M;LaPlant Q;Healey JH;Elemento O;Chung CH;Lee NY;Imielenski M;Nanjangud G;Pe'er D;Cleveland DW;Powell SN;Lammerding J;Swanton C;Cantley LC
通讯作者:
Cantley LC
影响因子:
64.8
作者:
Stewart E;Federico SM;Chen X;Shelat AA;Bradley C;Gordon B;Karlstrom A;Twarog NR;Clay MR;Bahrami A;Freeman BB 3rd;Xu B;Zhou X;Wu J;Honnell V;Ocarz M;Blankenship K;Dapper J;Mardis ER;Wilson RK;Downing J;Zhang J;Easton J;Pappo A;Dyer MA
通讯作者:
Dyer MA
影响因子:
2.9
作者:
Pereiro, P.;Varela, M.;Novoa, B.
通讯作者:
Novoa, B.
影响因子:
28.2
作者:
Drapkin BJ;George J;Christensen CL;Mino-Kenudson M;Dries R;Sundaresan T;Phat S;Myers DT;Zhong J;Igo P;Hazar-Rethinam MH;Licausi JA;Gomez-Caraballo M;Kem M;Jani KN;Azimi R;Abedpour N;Menon R;Lakis S;Heist RS;Büttner R;Haas S;Sequist LV;Shaw AT;Wong KK;Hata AN;Toner M;Maheswaran S;Haber DA;Peifer M;Dyson N;Thomas RK;Farago AF
通讯作者:
Farago AF
影响因子:
3.8
作者:
Cabezas-Sainz, Pablo;Guerra-Varela, Jorge;Sanchez, Laura
通讯作者:
Sanchez, Laura